Hyperhomocysteinemia, MTHFR, and Risk of Vascular Disease

Circulation - United States
doi 10.1161/01.cir.101.16.e171
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Treatment of Mild Hyperhomocysteinemia in Vascular Disease Patients

Arteriosclerosis and Thrombosis: A Journal of Vascular Biology
1994English

Contribution of Haptoglobin and MTHFR Polymorphisms to Hyperhomocysteinemia and Hypercysteinemia in Type 2 Diabetic Patients

Endocrine Abstracts
2015English

Incidence of Hyperhomocysteinemia and MTHFR C677T Polymorphism Among Young Patients With Acute Myocardial Infarction

Journal of Medical Biochemistry
BiochemistryClinical Biochemistry
2009English

Major Lipids, Apolipoproteins, and Risk of Vascular Disease

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2010English

Single Nucleotide Polymorphisms in Homocysteine Metabolism Pathway Genes: Association of CHDH A119C and MTHFR C677T With Hyperhomocysteinemia

Circulation: Cardiovascular Genetics
2009English

Is Hyperhomocysteinemia an Alzheimer's Disease (AD) Risk Factor, an AD Marker, or Neither?

Trends in Pharmacological Sciences
ToxicologyPharmacology
2011English

Role of Hyperhomocysteinemia in Endothelial Dysfunction and Atherothrombotic Disease

Cell Death and Differentiation
Cell BiologyMolecular Biology
2004English

Hyperhomocysteinemia Enhances Vascular Inflammation and Accelerates Atherosclerosis in a Murine Model

Journal of Clinical Investigation
Medicine
2001English

Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy